Literature DB >> 27127589

In Silico Analysis of the cadF Gene and Development of a Duplex Polymerase Chain Reaction for Species-Specific Identification of Campylobacter jejuni and Campylobacter coli.

Saeed Shams1, Bita Bakhshi1, Tahereh Tohidi Moghadam2.   

Abstract

BACKGROUND: Campylobacteriosis is a zoonotic infectious disease caused by Campylobacter jejuni and C. coli. The cadF gene is considered as a genus-specific gene while other genes are mainly used for discrimination at the species level.
OBJECTIVES: This study aimed to analyze the cadF gene and to develop a duplex PCR assay for simultaneous detection of C. coli and C. jejuni, the two commonly encountered species.
MATERIALS AND METHODS: In silico analysis of the cadF gene was carried out by several software and available online tools. A duplex PCR optimized with specific primers was used for detection and differentiation of both species. To evaluate specificity and sensitivity of the test, a panel of different Campylobacter spp. together with several intestinal bacterial pathogens was tested. The limit of detection (LOD) of method was determined using serial dilutions of standard genomes.
RESULTS: The analysis of the full size cadF gene indicated variations in this gene, which can be used to differentiate C. jejuni and C. coli. The duplex PCR designed in this study showed that it could simultaneously detect and differentiate both C. jejuni and C. coli with product sizes of 737 bp and 461 bp, respectively. This assay, with 100% specificity and sensitivity, had a limit of detection (LOD) of about 14 and 0.7 µg/mL for C. jejuni and C. coli, respectively.
CONCLUSIONS: In silico analysis of the cadF full-gene showed variations between the two species that can be used as a molecular target for differentiating C. jejuni and C. coli in a single-step duplex-PCR assay with high specificity and sensitivity.

Entities:  

Keywords:  C. coli; Campylobacter jejuni; Duplex PCR; In Silico; cadF

Year:  2016        PMID: 27127589      PMCID: PMC4842252          DOI: 10.5812/jjm.29645

Source DB:  PubMed          Journal:  Jundishapur J Microbiol        ISSN: 2008-3645            Impact factor:   0.747


1. Background

Campylobacter enteritis is one of the most frequent food-borne infections worldwide (1). Thermophilic C. jejuni and C. coli have been recognized as the most common causes of bacterial diarrhea in humans, especially among children less than five years of age and young adults (2). Although, poultry and poultry products are important sources of Campylobacteriosis, yet the organism can be transmitted to humans via contact with other warm-blooded animals such as cattle, pigs, sheep, ostriches, shellfish, and pets (3, 4). The symptoms of campylobacteriosis can vary from mild to severe complications, including abdominal pain, fever, myalgia and watery or bloody diarrhea. Although, in most cases the illness is self-limited and rarely fatal yet post-infectious acute immune-mediated neurologic complications such as Guillain-Barre syndrome and Miller Fisher syndrome can occur, which are the consequence of molecular mimicry between lipooligosaccharides (LOS) of bacterial cell wall and gangliosides in peripheral nerves of humans (5, 6). These complications can be prevented or lowered with rapid and accurate detection of etiological agents of the disease. Diagnosis of campylobacteriosis is performed through microbiological, molecular and serological tests. Culture is the gold standard of diagnosis of C. coli and C. jejuni; however, the culture conditions for detection of these fastidious bacteria are complicated and time consuming, which in some cases make the recovery of bacteria unsuccessful. Moreover, the emergence of viable but non-culturable (VBNC) phenotypes should not be ignored. Differentiation of the two species is only performed through hippurate hydrolysis biochemical test or molecular-based detections (7-10). In molecular methods different genetic targets have been used for the detection Campylobacter species (e.g. asp, hipO, ceuE, cadF, 16SrRNA, 23S rRNA and cdt, fur, glyA, cdtABC, ceuB–E and fliY) (9). Among them, the cadF gene encodes a fibronectin-binding protein that promotes bacteria-host cell interaction and has been described as a conserve and genus-specific gene. In most studies a fragment from this gene with a length of 400 bp is used for identification of Campylobacter spp. at the genus level (1, 11-15). There is no documented bioinformatics study on the cadF gene full-sequence analysis in C. jejuni and C. coli.

2. Objectives

The aim of this study was to analyze the cadF gene and to develop and evaluate a single-step duplex polymerase chain reaction (PCR) assay for simultaneous detection of C. coli and C. jejuni, the two commonly encountered species in human Campylobacteriosis.

3. Materials and Methods

3.1. Alignment of cadF Sequences From GenBank

The cadF sequences from the complete genome of C. jejuni and C. coli were acquired from NCBI GenBank (http://www.ncbi.nlm.nih.gov/) (Table 1). Multiple alignments were performed using the CLC sequence viewer 7.6 software (CLC bio, Aarhus, Denmark).
Table 1.

CampylobactercadF Sequences Used in This Study

DefinitionAccession No.
Campylobacter jejuni subsp. jejuni strain MTVDSCj20, complete genome CP008787.1
Campylobacter jejuni subsp. jejuni 00-2538, complete genome CP006707.2
Campylobacter jejuni subsp. jejuni 00-2544, complete genome CP006709.2
Campylobacter jejuni subsp. jejuni PT14, complete genome NC_018709.2
Campylobacter jejuni subsp. jejuni NCTC 11168 complete genome AL111168.1
Campylobacter jejuni RM1221, complete genome CP000025.1
Campylobacter jejuni subsp. jejuni 81116, complete genome CP000814.1
Campylobacter coli RM2228 cont193, whole genome shotgun sequence AAFL01000010.1
Campylobacter coli RM1875, complete genome CP007183.1
Campylobacter coli 15-537360, complete genome CP006702.1
Campylobacter coli RM5611, complete genome CP007179.1
Campylobacter coli CVM N29710, complete genome CP004066.1
Campylobacter coli RM4661, complete genome CP007181.1
Campylobacter coli JV20 contig00034, whole genome shotgun sequence AEER01000022.1
Campylobacter coli JV20 genomic scaffold SCAFFOLD1, whole genome shotgun sequence GL405235.1

3.2. In Silico Analysis of the cadF Gene

The conserved internal fragment (400 bp) of the cadF gene, reported by Konkel et al. (15) as a specific gene for detection of Campylobacter spp., was used as a reference sequence in this study. This fragment and other selected sequences from the full gene of cadF were subjected to in silico analysis with the online NEB cutter program (http://tools.neb.com/NEBcutter) to compare and select a proper restriction endonuclease for discriminating between C. jejuni and C. coli using analysis of enzymatic digestion pattern.

3.3. Designing a Duplex Polymerase Chain Reaction Assay for Specific Detection of Campylobacter jejuni and C. coli

The entire cadF sequence obtained from GenBank was robustly examined for the presence of intra-species conserved regions, which could differentiate inter-species. Universal forward primer, FU, (position 101 - 120) and reverse primer, R1, (position 478 - 497) were selected for the cadF gene, and were previously described by Konkel et al. (15). Other reverse primers, R2 (position 542 - 561) and R3 (position 818 - 837), were designed in this study using the Genrunner and CLC sequence viewer software (Table 2). Analysis of the designed primers was performed by the Primer-BLAST on NCBI (http://www. ncbi.nlm.nih.gov/). Schematic representation of the PCR amplification of fragments related to C. jejuni and C. coli in duplex PCR is shown in Figure 1. Oligonucleotide primers were synthesized by TAG Copenhagen (Denmark).
Table 2.

Primer Sequences for the cadF Gene Used in the Duplex Polymerase Chain Reaction Assay[a]

PrimerSequence ( 5' to 3' )Size of Product, bpTargetReference
FU TTGAAGGTAATTTAGATATG400Campylobacter spp.(15)
R1 CTAATACCTAAAGTTGAAAC400Campylobacter spp(15)
R2 TTTATTAACTACTTCTTTTG461 C. coli This study
R3 ATATTTTTCAAGTTCATTAG737 C. jejuni This study

aAnnealing temperature is 43°C for all the primers.

Figure 1.

Position of Primers for Developing the Duplex Polymerase Chain Reaction Assay

Black thin lines of 999 and 960 bp are related to the cadF gene of C. coli and C. jejuni, respectively. The discontinuity is related to deletion in C. jejuni. A, produced a 400-bp fragment from both C. jejuni and C. coli (as the positive control of the assay); B, produced a 461-bp fragment from C. coli; C, produced a 737-bp fragment from C. jejuni.

aAnnealing temperature is 43°C for all the primers.

Position of Primers for Developing the Duplex Polymerase Chain Reaction Assay

Black thin lines of 999 and 960 bp are related to the cadF gene of C. coli and C. jejuni, respectively. The discontinuity is related to deletion in C. jejuni. A, produced a 400-bp fragment from both C. jejuni and C. coli (as the positive control of the assay); B, produced a 461-bp fragment from C. coli; C, produced a 737-bp fragment from C. jejuni. The duplex-PCR was carried out in a 25-μL reaction mixture, containing 10 ng of DNA template extracted by the boiling method, 2.5 μL PCR buffer 10X, 200 μM dNTP, 5 mM MgCl2, 0.1 μM of each primer, 1 unit of Taq DNA polymerase, and sterile deionized water (12, 14). Amplification conditions were 95°C for three minutes (one cycle), then denaturation at 94°C for 30 seconds, annealing at 43°C for 30 seconds and extension at 72°C for 30 seconds for 32 cycles in a thermocycler (Eppendorf, Hamburg, Germany). Finally, an additional extension step (five minutes, 72°C) was carried out.

3.4. Limit of Detection, Sensitivity and Specificity of the Duplex Polymerase Chain Reaction

Limit of detection (LOD) of the amplification assay was evaluated using serial 10-fold dilutions of genomes with initial concentrations of 140 (C. jejuni) and 7 (C. coli) µg/mL. A total of 20 clinical and environmental Campylobacter isolates were examined for further evaluation of the sensitivity. Specificity of the test was evaluated using genomic DNA from standard and isolated clinical strains of other enteric non-Campylobacter bacterial pathogens (Table 3). Sensitivity and specificity were calculated according to the following Equations (16):
Table 3.

List of Bacteria Used for the Determination of Specificity and Sensitivity of cadF-Targeted Species-Specific Duplex Polymerase Chain Reaction[a]

Organism NameStrain NameAmplification with Newly Designed Primers
Shigella sonnei ATCC 25931negative
Shigella flexneri ATCC 12022negative
Shigella boydii ATCC 8700negative
Shigella dysenteriae ATCC 13313negative
Aeromonas hydrophila ATCC 7966negative
Enterobacter aerogenes ATCC 13048negative
Vibrio cholerae ATCC 39315negative
Enteropathogenic Escherichia coli ATCC 43887negative
Escherichia coli O157:H7 ATCC 35150negative
Enteroinvasive Escherichia coli ATCC 43893negative
Enteroaggregative Escherichia coli ATCC 33780negative
Enterotoxigenic Escherichia coli ATCC 35401negative
Salmonella typhimurium ATCC 29946negative
Salmonella typhi ATCC 19430negative
Campylobacter jejuni ATCC 29428positive
Campylobacter coli ATCC 43478positive
Campylobacter coli Isolate 1positive
Campylobacter coli Isolate 2positive
Campylobacter coli Isolate 3positive
Campylobacter coli Isolate 4positive
Campylobacter coli Isolate 5positive
Campylobacter coli Isolate 6positive
Campylobacter coli Isolate 7positive
Campylobacter coli Isolate 8positive
Campylobacter coli Isolate 9positive
Campylobacter jejuni Isolate 1positive
Campylobacter jejuni Isolate 2positive
Campylobacter jejuni Isolate 3positive
Campylobacter jejuni Isolate 4positive
Campylobacter jejuni Isolate 5positive
Campylobacter jejuni Isolate 6positive
Campylobacter jejuni Isolate 7positive
Campylobacter jejuni Isolate 8positive
Campylobacter jejuni Isolate 9positive
Campylobacter jejuni Isolate 10positive
Campylobacter jejuni Isolate 11positive

aSource of isolations is clinical.

aSource of isolations is clinical.

4. Results

4.1. In Silico Analysis of the cadF Gene

The length of the cadF sequences extracted from complete genome of C. jejuni and C. coli was 960 (with C + G 31.8% and A + T 68.2%) and 999 bp (with C + G 34% and A + T 66%), respectively. The cadF gene in both species was located after the rpsI gene, which coded for a 30S ribosomal protein. Although there were some nucleotide variations along the sequence of cadF between the two species, yet the main difference was related to the 39-bp deletion in the positions of 533 - 544 and 560 - 586 of C. jejuni (Figure 2). The results of the BLAST analysis of cadF gene showed an average sequence identity of 98.5% and 94% among C. jejuni and C. coli strains, respectively. The identity between the two species was also estimated as 88%, approximately (Table 4).
Figure 2.

Analysis and Multiple Alignment of the cadF Complete Gene of Campylobacter jejuni (960 bp) and C. coli (999 bp) by the CLC Software

Dashes in the lower box indicate deleted nucleotides in C. jejuni. The blue box is the conserved 400-bp internal region introduced by Konkel et al.

Table 4.

The Distribution of Nucleotides and the Percentage Identity of the cadF Gene

Values
Campylobacter spp.
C. jejuni [a]
C + G305 (31.8)
A + T655 (68.2)
C. coli [a]
C + G340 (34)
A + T660 (66)
Identity between strains, %
C. jejuni and C. jejuni 97 - 100
C. coli and C. coli 88 - 100
C. jejuni and C. coli 85 - 91

aValue are presented as No. (%).

Analysis and Multiple Alignment of the cadF Complete Gene of Campylobacter jejuni (960 bp) and C. coli (999 bp) by the CLC Software

Dashes in the lower box indicate deleted nucleotides in C. jejuni. The blue box is the conserved 400-bp internal region introduced by Konkel et al. aValue are presented as No. (%). The analysis of the cadF gene 400-bp product sequence (Figure 2), introduced by Konkel et al. via the NEBcutter online web site, indicated that this part of the gene is conserved and there are no commercially proper restriction enzymes to produce fragments with good intervals to differentiate between C. jejuni and C. coli (15) The selected segments of the cadF gene in this study were theoretically appropriate for enzymatic digestions and the produced fragments could be used for species differentiation.

4.2. Design and Evaluation of a Species-Specific Duplex Polymerase Chain Reaction Assay

Duplex PCR showed that it could simultaneously detect both C. jejuni and C. coli with product sizes of 737 bp and 461 bp, respectively (Figure 3). Specificity and sensitivity of the duplex PCR assay was determined to be 100% with exclusive amplification for C. jejuni and C. coli, while this result was negative for other non-Campylobacter enteric bacterial species. The assay showed limit of detection (LOD) of 14 and 0.7 µg/mL (approximately equal to 7 × 109 and 3 × 108 copy number) for C. jejuni and C. coli, respectively.
Figure 3.

Agarose Gel Electrophoresis of the Duplex Polymerase Chain Reaction Assay with Specific Primers

Lanes 1 and 2, 400-bp fragment of the cadF gene of Campylobacter jejuni and Campylobacter coli, respectively as positive controls; lanes 4 - 6, 737 bp fragment of C. jejuni; lanes 9 - 11, 461 bp fragment of C. coli; lanes 3, 7, 8, 12 and 13, negative controls; lane M, 1 kb molecular weight marker.

Agarose Gel Electrophoresis of the Duplex Polymerase Chain Reaction Assay with Specific Primers

Lanes 1 and 2, 400-bp fragment of the cadF gene of Campylobacter jejuni and Campylobacter coli, respectively as positive controls; lanes 4 - 6, 737 bp fragment of C. jejuni; lanes 9 - 11, 461 bp fragment of C. coli; lanes 3, 7, 8, 12 and 13, negative controls; lane M, 1 kb molecular weight marker.

5. Discussion

Campylobacter jejuni and C. coli are now recognized as important causes of acute bacterial diarrhea in most countries. The isolation and discrimination of C. jejuni and C. coli by biochemical tests at the species level is limited and laborious, thus there is a crucial need to develop a sensitive, validated and rapid DNA-based method for detection of Campylobacter at the species level (10, 17). In some studies, multiple genes have been used for distinguishing C. jejuni and C. coli. Al Amri et al. (2007) developed a multiplex PCR assay using the combination of a genus-specific virulence gene (cadF) together with hippuricase and aspartokinase genes (asp) for species-specific identification of C. jejuni and C. coli, respectively (11). In a study by Cloak and Fratamico (2002), a multiplex PCR was designed for differentiation of C. jejuni and C. coli by means of cadF and ceuE genes. In another work by Adzitey and Corry (2011), lpxA, hipO and glyA genes were used for differentiating C. jejuni and C. coli species. The study of Nayak et al. (2005) was also designed with cadF, ceuE and oxidoreductase subunit genes as fragments of 400-bp conserved region in Campylobacter spp. 894-bp specific for C. coli and 160-bp specific for C. jejuni, respectively (14, 18, 19). Our duplex PCR method was developed only with the cadF gene and the specificity and sensitivity of novel reverse primers (R2 and R3) in association with a previously described forward primer (FU) was studied. The PCR assay designed in this work showed 100% sensitivity and specificity while no amplification product was seen for the genomic DNA from non-Campylobacter enteric bacteria. One applicable advantage of this newly designed duplex PCR assay is that the amplified products are of different sizes, which can be concurrently visualized on agarose gel without the need to duplicate the reaction or further electrophoresis and sequencing. In a similar study, Klena et al. used divergence and conservation regions of lpxA to develop a robust PCR assay. They differentiated C. coli, C. jejuni, C. lari and C. upsaliensis using multiplex PCR with the lipid A gene lpxA, encoding a UDP-N- acetyl glucosamine acyl transferase. Another work similar to our research was the study of Gonzalez et al. They discriminated C. jejuni and C. coli by using ceuE gene diversity (approximately 13%) between two species (20, 21). The lowest concentration of genomic DNA for detection of C. jejuni and C. coli was 14 and 0.7 µg/mL (approximately equal to 7 × 109 and 3 × 108 copy number), respectively. These LODs are almost comparable with the study conducted by Wisessombat et al., in which the sensitivity of the multiplex PCR for the detection of Campylobacter spp. was 2 × 105 CFU/PCR (22). Another study indicated that the colony multiplex PCR sensitivity range for C. jejuni and C. coli was 108 to 1013 and 106 to 1013 CFU/mL, respectively (23). The bioinformatics data analysis of the 400-bp internal section of the cadF introduced by Konkel et al. which has been used by many investigators for genus-specific detection of Campylobacter spp. showed that this fragment is highly conserved among C. jejuni and C. coli strains and is significantly validated for the identification of both species. It seems that there is a concomitant general misjudged belief that the cadF full-gene is genus-specific. Our analysis of total cadF sequence revealed that other than single-nucleotide variations between two bacteria, an approximately 4% deletion has occurred in the cadF sequence of C. jejuni compared with C. coli, which could be useful for our work. The intra-species identity level among C. jejuni and C. coli strains was about 98.5% and 94%, respectively. The identity level was approximately 88% between the two species. These results were similar to the report of Konkel et al. with 87% identity between C. jejuni and C. coli and 98.6% among C. jejuni strains, individually (15). There are several articles about the PCR-RFLP method for the differentiation of Campylobacter spp. using genes other than cadF (24, 25). Although the restriction pattern of enzymatic digestion of the 400-bp fragment introduced by Konkel et al. is not suitable for separation of the two species, yet the enzymatic digestion of the full-length gene may be useful for differentiation and clinical diagnosis of C. jejuni and C. coli (15) The cadF full-gene has some variations in its sequence and length between species, which can be beneficial for developing a duplex PCR. The designed PCR assay in this study is highly sensitive and specific and provides an accurate, inexpensive, sensitive and specific tool for rapid and simultaneous detection and differentiation of C. coli and C. jejuni in clinical settings.
  23 in total

Review 1.  Campylobacter and bacterial gastroenteritis.

Authors:  Eleni Galanis
Journal:  CMAJ       Date:  2007-09-11       Impact factor: 8.262

2.  A rapid and reliable species-specific identification of clinical and environmental isolates of Vibrio cholerae using a three-test procedure and recA polymerase chain reaction.

Authors:  A D Roozbehani; B Bakhshi; M R Pourshafie; M Katouli
Journal:  Indian J Med Microbiol       Date:  2012 Jan-Mar       Impact factor: 0.985

3.  A multiplex polymerase chain reaction for the differentiation of Campylobacter jejuni and Campylobacter coli from a swine processing facility and characterization of isolates by pulsed-field gel electrophoresis and antibiotic resistance profiles.

Authors:  Orla M Cloak; Pina M Fratamico
Journal:  J Food Prot       Date:  2002-02       Impact factor: 2.077

4.  Colony multiplex PCR assay for identification and differentiation of Campylobacter jejuni, C. coli, C. lari, C. upsaliensis, and C. fetus subsp. fetus.

Authors:  Gehua Wang; Clifford G Clark; Tracy M Taylor; Chad Pucknell; Connie Barton; Lawrence Price; David L Woodward; Frank G Rodgers
Journal:  J Clin Microbiol       Date:  2002-12       Impact factor: 5.948

Review 5.  Campylobacteriosis - an overview.

Authors:  S R Sarkar; M A Hossain; S K Paul; N C Ray; S Sultana; M M Rahman; A Islam
Journal:  Mymensingh Med J       Date:  2014-01

6.  CadF expression in Campylobacter jejuni strains incubated under low-temperature water microcosm conditions which induce the viable but non-culturable (VBNC) state.

Authors:  Vania Patrone; Raffaella Campana; Luciana Vallorani; Sabrina Dominici; Sara Federici; Lucia Casadei; Anna Maria Gioacchini; Vilberto Stocchi; Wally Baffone
Journal:  Antonie Van Leeuwenhoek       Date:  2013-01-13       Impact factor: 2.271

7.  Detection of campylobacter species: a comparison of culture and polymerase chain reaction based methods.

Authors:  S P Kulkarni; S Lever; J M J Logan; A J Lawson; J Stanley; M S Shafi
Journal:  J Clin Pathol       Date:  2002-10       Impact factor: 3.411

8.  Detection of Campylobacter jejuni and Campylobacter coli from broiler chicken-related samples using BAX PCR and conventional International Organization for Standardization culture.

Authors:  Lisa K Williams; Alisdair McMeechan; Tamsin Baalham; Laura Ward; Tom J Humphrey; Frieda Jørgensen
Journal:  J Food Prot       Date:  2008-04       Impact factor: 2.077

9.  Use of culture, PCR analysis, and DNA microarrays for detection of Campylobacter jejuni and Campylobacter coli from chicken feces.

Authors:  Georgios Keramas; Dang Duong Bang; Marianne Lund; Mogens Madsen; Henrik Bunkenborg; Pieter Telleman; Claus Bo Vöge Christensen
Journal:  J Clin Microbiol       Date:  2004-09       Impact factor: 5.948

10.  A molecular survey of Campylobacter jejuni and Campylobacter coli virulence and diversity.

Authors:  Mahdi Ghorbanalizadgan; Bita Bakhshi; Anoshirvan Kazemnejad Lili; Shahin Najar-Peerayeh; Bahram Nikmanesh
Journal:  Iran Biomed J       Date:  2014-07
View more
  5 in total

1.  Prevalence, molecular detection, and virulence gene profiles of Campylobacter species in humans and foods of animal origin.

Authors:  Ashraf M A Barakat; Khaled A Abd El-Razik; Hassan A Elfadaly; Nagwa S Rabie; Sabry A S Sadek; Abdulaziz M Almuzaini
Journal:  Vet World       Date:  2020-07-24

2.  High prevalence of Campylobacter jejuni CC21 and CC257 clonal complexes in children with gastroenteritis in Tehran, Iran.

Authors:  Mahnaz Sarhangi; Bita Bakhshi; Shahin Najar Peeraeyeh
Journal:  BMC Infect Dis       Date:  2021-01-23       Impact factor: 3.090

3.  In silico analysis of epitope-based CadF vaccine design against Campylobacter jejuni.

Authors:  Mona Moballegh Naseri; Saeed Shams; Mohammad Moballegh Naseri; Bita Bakhshi
Journal:  BMC Res Notes       Date:  2020-11-10

4.  Imipenem resistance in clinical Escherichia coli from Qom, Iran.

Authors:  Saeed Shams; Ali Hashemi; Mohammad Esmkhani; Somaye Kermani; Elham Shams; Alessandra Piccirillo
Journal:  BMC Res Notes       Date:  2018-05-18

5.  Whole genome sequencing reveals extended natural transformation in Campylobacter impacting diagnostics and the pathogens adaptive potential.

Authors:  Julia C Golz; Lennard Epping; Marie-Theres Knüver; Maria Borowiak; Felix Hartkopf; Carlus Deneke; Burkhard Malorny; Torsten Semmler; Kerstin Stingl
Journal:  Sci Rep       Date:  2020-02-28       Impact factor: 4.379

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.